What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His main research concerns Internal medicine, Cancer, Relative survival, Odds ratio and Gynecology.
His Internal medicine study combines topics from a wide range of disciplines, such as Surgery and Oncology.
His Cancer study combines topics in areas such as Endocrinology and Mass screening.
He interconnects Hematopoietic stem cell transplantation, Transplantation, Survival rate, Survival analysis and Pediatrics in the investigation of issues within Relative survival.
His Odds ratio study incorporates themes from Body mass index, Case-control study and Obstetrics.
His studies deal with areas such as Progression-free survival and Sexual function as well as Gynecology.
His most cited work include:
- Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. (1120 citations)
- Regression models for relative survival. (669 citations)
- Quality of Life after Radical Prostatectomy or Watchful Waiting (631 citations)
What are the main themes of his work throughout his whole career to date?
Paul W. Dickman mainly focuses on Internal medicine, Relative survival, Cancer, Survival analysis and Oncology.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Surgery.
His research integrates issues of Survival rate, Statistics and Pediatrics in his study of Relative survival.
His Cancer research is multidisciplinary, incorporating perspectives in Incidence, Patient survival, Life expectancy, Disease and Population based.
His Survival analysis research is multidisciplinary, incorporating elements of Mortality rate, Parametric statistics, Cause of death and Gerontology.
His studies in Case-control study integrate themes in fields like Odds ratio and Hormone replacement therapy.
He most often published in these fields:
- Internal medicine (40.27%)
- Relative survival (32.30%)
- Cancer (30.53%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (40.27%)
- Cancer (30.53%)
- Relative survival (32.30%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Cancer, Relative survival, Hazard ratio and Survival analysis are his primary areas of study.
His Internal medicine study frequently links to adjacent areas such as Oncology.
His Cancer research incorporates themes from Survival rate, Epidemiology, Incidence and Public health.
His research in Relative survival intersects with topics in Stage, Life expectancy, Absolute risk reduction and Disease.
While the research belongs to areas of Hazard ratio, Paul W. Dickman spends his time largely on the problem of Proportional hazards model, intersecting his research to questions surrounding Obstetrics and Leukoreduction.
His research investigates the connection between Survival analysis and topics such as Mortality rate that intersect with issues in Poisson distribution and Socioeconomic status.
Between 2015 and 2021, his most popular works were:
- Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. (1120 citations)
- Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population (320 citations)
- Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms: A Population-Based Cohort Study (61 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His primary scientific interests are in Internal medicine, Cancer, Hazard ratio, Cohort study and Young adult.
His research brings together the fields of Oncology and Internal medicine.
The study incorporates disciplines such as Head and neck cancer and Proportional hazards model in addition to Oncology.
His Cancer research is multidisciplinary, relying on both Survival rate and Hepatology.
The Young adult study combines topics in areas such as Pregnancy, Relapse risk, Gynecology and Hodgkin lymphoma.
His Confidence interval research is multidisciplinary, incorporating perspectives in Clinical trial, Relative survival, Life expectancy, Disease and Survival analysis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
